financetom
Business
financetom
/
Business
/
Centre has the right to regulate Online Gaming: MeitY tells Delhi High Court
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Centre has the right to regulate Online Gaming: MeitY tells Delhi High Court
Nov 18, 2023 1:59 PM

The central government has submitted its response to the Delhi High Court in the case brought by the Social Organization for Creating Humanity (SOCH). The NGO had challenged the constitutional and legislative validity of the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Amendment Rules, 2023, which aim to regulate online gaming.

Share Market Live

NSE

In a robust defence of its legislative competence, the government cites the Constitution of India, asserting its authority under Entry 31 of List I (Union List) and Entry 97 (residual powers) to regulate matters of online gaming, which transcends state boundaries and falls within the realm of 'Inter-State trade and commerce'.

The government's response comes after SOCH contended that these rules exceeded the central government's legislative competence and resulted in regulatory confusion. The case has raised questions about the division of powers between the central and state governments regarding online gaming regulation.

Labeling the plea as a proxy litigation, the government's reply contends that SOCH lacks the necessary legal standing to challenge the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Amendment Rules, 2023. The Ministry of Electronics and Information Technology (MeitY) emphasises that the rules were framed after comprehensive stakeholder consultations and that the MeitY had allowed for public commentary on the draft rules, a process in which SOCH did not participate.

The central government also contended that the NGO's claim of outsourcing regulatory responsibilities, clarifying that the formation of self-regulatory bodies (SRBs) is part of a larger framework intended to bolster the safety and integrity of online gaming platforms.

(Edited by : Keshav Singh Chundawat)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Osisko Gold Royalties Books Record Preliminary Q4 2024 Revenue; Keeps Outperform Rating at National Bank of Canada
Update: Osisko Gold Royalties Books Record Preliminary Q4 2024 Revenue; Keeps Outperform Rating at National Bank of Canada
Jan 7, 2025
10:58 AM EST, 01/07/2025 (MT Newswires) -- Osisko Gold Royalties ( OR ) reported Tuesday record preliminary fourth-quarter revenue. Osisko posted record revenue from royalties and streams of $79.3 million and cost of sales of $3.1 million, resulting in a record quarterly cash margin of $76.3 million. The company said it earned 20,005 attributable gold equivalent ounces (GEO) for a...
Pacira Biosciences Gets FDA Clearance for Chronic Low Back Pain Treatment
Pacira Biosciences Gets FDA Clearance for Chronic Low Back Pain Treatment
Jan 7, 2025
10:56 AM EST, 01/07/2025 (MT Newswires) -- Pacira Biosciences ( PCRX ) said Tuesday it has received clearance from the US Food & Drug Administration to market a new Smart Tip designed to access the medial branch nerves to manage chronic low back pain. The iovera system relieves pain via cryoneurolysis -- a process whereby focused cold therapy is applied...
Micron Technology Unusual Options Activity For January 07
Micron Technology Unusual Options Activity For January 07
Jan 7, 2025
Deep-pocketed investors have adopted a bullish approach towards Micron Technology ( MU ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MU usually suggests something big is about to happen. We gleaned this information...
Immix Biopharma Says Patients Dosed in AL Amyloidosis Trial Safety Run-in Successfully Complete Safety Evaluation
Immix Biopharma Says Patients Dosed in AL Amyloidosis Trial Safety Run-in Successfully Complete Safety Evaluation
Jan 7, 2025
10:56 AM EST, 01/07/2025 (MT Newswires) -- Immix Biopharma ( IMMX ) said Tuesday six patients dosed in a phase 1b safety run-in segment of a trial of its experimental NXC-201 treatment of relapsed or refractory AL Amyloidosis successfully completed the trial's safety evaluation. The safety run-in segment dosed three patients at 150 million CAR-T cells and three patients at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved